May. 28 at 3:26 AM
$BB Go
$BB Go....
Another Canadian
$BCTX . Keep an eye. Very low float. Anytime can start fly.
$BCTX
✔️ 6th straight positive DSMB review
✔️ No safety concerns
✔️ Phase 3 continues unchanged
If a DSMB releases a highly positive report indicating that a drug is incredibly safe and highly effective (e.g., passing a major Phase 2 or Phase 3 trial milestone), it increases the asset's value. This success often triggers Big Pharma to approach the smaller biotech company for a buyout to secure the drug before it goes to market. Conversely, a negative DSMB report (indicating poor efficacy or unacceptable toxicity) typically tanks the asset's value and deters buyouts
